Report finds $529M overpayment for anemia drugs in 2011

05/13/2013 | Fox Business

An Office of Inspector General report found that Medicare overpaid by $529 million for anemia drugs given to dialysis patients in 2011. Had U.S. government spending been based on current drug usage levels, which have fallen since 2007, the government would have saved $510 million. A decline in the use of iron deficiency drugs led to an overpayment of $19 million, the report said. CMS is expected to release a proposal this summer to change next year's reimbursement rate.

View Full Article in:

Fox Business

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI
Vice President of Finance
Urban Health Plan, Inc.
Bronx, NY
Director of Payor/Provider Contracting
U.S. Medical Management
Tryo, MI